September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Early detection of visual field conversion using an unsupervised machine-learning analysis of retinal nerve fiber layer thickness measurements
Author Affiliations & Notes
  • Siamak Yousefi
    Ophthalmology, University of California San Diego, La Jolla, California, United States
  • Michael Henry Goldbaum
    Ophthalmology, University of California San Diego, La Jolla, California, United States
  • Ehsan Shahrian Varnousfaderani
    Ophthalmology, University of California San Diego, La Jolla, California, United States
  • Linda M Zangwill
    Ophthalmology, University of California San Diego, La Jolla, California, United States
  • Felipe A Medeiros
    Ophthalmology, University of California San Diego, La Jolla, California, United States
  • Robert N Weinreb
    Ophthalmology, University of California San Diego, La Jolla, California, United States
  • Christopher A Girkin
    Ophthalmology, University of Alabama, Birmingham, Birmingham, Alabama, United States
  • Jeffrey M Liebmann
    Ophthalmology, Columbia University, New York, New York, United States
  • Christopher Bowd
    Ophthalmology, University of California San Diego, La Jolla, California, United States
  • Footnotes
    Commercial Relationships   Siamak Yousefi, None; Michael Goldbaum, None; Ehsan Shahrian Varnousfaderani, None; Linda Zangwill, Carl Zeiss Meditec Inc (F), Carl Zeiss Meditec Inc (R), Heidelberg Engineering GmbH (F), Optovue Inc. (F), Optovue Inc. (R), Quark (F), Topcon Medical Systems Inc. (F); Felipe Medeiros, Alcon (C), Allergan (F), Allergan (C), Ametek (F), Ametek (C), Bausch+Lomb (F), Carl-Zeiss Meditec (F), Carl-Zeiss Meditec (C), Carl Zeiss Meditec Inc (R), Heidelberg Engineering (C), Heidelberg Engineering GmbH (F), Sensimed (F), Topcon (F); Robert Weinreb, Alcon (C), Allergan (C), Amatek (C), Bausch+Lomb (C), Carl Zeiss Meditec (C), Carl Zeiss Meditec (F), Carl Zeiss Meditec (R), Forsight (C), Genentech (F), Heidelberg Engineering (F), Konan (F), National Eye Institute (F), Neurovision (F), Optovue (F), Quark (F), Reichert (F), Tomey (F), Topcon (C), Topcon (F), Valeant (C); Christopher Girkin, Carl Zeiss Meditech, Inc. (F), EyeSight Foundation of Alabama (F), Heidelberg Engineering, GmbH (F), National Eye Institute (F), Research to Prevent Blindness (F), SOLX (F); Jeffrey Liebmann, Allergan, Inc. (F), Bausch & Lomb, Inc. (F), Bausch & Lomb, Inc. (C), Carl Zeiss Meditech, Inc (C), Carl Zeiss Meditech, Inc (F), Diopysis, inc. (C), Diopysis, inc. (E), Heidelberg Engineering, GmbH (C), Heidelberg Engineering, GmbH (F), Merz Phamaceuticals, Inc. (C), National Eye Institute (F), New York Glaucoma Research Institute (F), Optovue (F), Quark Pharmaceuticals, Inc. (C), Reichert, Inc. (C), Sensimed, Inc. (C), SOLX, Inc. (E), Sustained Nano System (E), Topcon, Inc. (F), Valeant Pharmaceutiicals, Inc. (C); Christopher Bowd, None
  • Footnotes
    Support  NIH R01EY022039, NIH R01EY011008, NIH R01EY019869, NIH R01EY021818, P30EY022589, NIH R01EY008208, U10EY14267, EY023704, Eyesight Foundation of Alabama; Merck Inc.; Santen Inc.; and the Edith C. Blum Research Fund of the New York Glaucoma Research Institute, New York, NY, Unrestricted grant from Research to Prevent Blindness, New York, New York, participant retention incentive grants in the form of glaucoma medication at no cost from Alcon Laboratories Inc., Allergan Inc., Pfizer Inc., Santen Inc., and unrestricted grant from Research to Prevent Blindness, New York, New York.
Investigative Ophthalmology & Visual Science September 2016, Vol.57, No Pagination Specified. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Siamak Yousefi, Michael Henry Goldbaum, Ehsan Shahrian Varnousfaderani, Linda M Zangwill, Felipe A Medeiros, Robert N Weinreb, Christopher A Girkin, Jeffrey M Liebmann, Christopher Bowd; Early detection of visual field conversion using an unsupervised machine-learning analysis of retinal nerve fiber layer thickness measurements. Invest. Ophthalmol. Vis. Sci. 201657(12):.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To determine if glaucomatous visual field conversion can be detected by machine-learning analysis of retinal nerve fiber layer thickness (RNFLT) measurements prior to glaucomatous visual field conversion

Methods : Study participants were recruited from the Diagnostic Innovations in Glaucoma Study (DIGS) and the African Descent and Glaucoma Evaluation Study (ADAGES). Longitudinal RNFLT measurements (Spectralis RNFL circle scan protocol, 768 A-scans; 64 RNFL sectors were generated by averaging 12 contiguous A-scans to reduce noise and any possible misalignment) from 74 eyes of 68 patients followed clinically (minimum 3 visits before conversion date) for suspicion of glaucoma were analyzed using Gaussian mixture model using expectation maximization (GEM) progression of patterns (POP) prior to conversion to glaucoma (conversion was defined as ≥ 3 consecutive abnormal SAP results by GHT or PSD ≤ 0.05). Previous cross-sectional GEM analyses of RNFLT measurements identified 7 glaucomatous RNFL patterns (axes) of loss (Yousefi et al., ARVO 2015). To define the conversion limit for GEM, longitudinal RNFLT measurements of 83 stable glaucoma eyes (imaged once a week for approximately 5 weeks, approximately 120 permuted series per eye) were analyzed across each axis and the rate of change was approximated using linear regression (LR). The conversion limit for each axis was adjusted to result in an overall 95th percentile conversion limit. To detect conversion, the longitudinal RNFLT measurements of patient eyes were analyzed across each GEM axis and the rate of change was approximated by LR. Conversion was assigned if the rate of change in an eye, along any GEM axis, was greater than the conversion limit for that axis; otherwise, no conversion was assumed. The early detection rate (defined as percentage of convert eyes correctly identified) of GEM was compared to that of LR of RNFLT global average, using the same method for setting conversion limits.

Results : GEM detected 88% of converted eyes prior to the first of 3 consecutive abnormal SAP results and linear regression of average RNFLT detected 62%. Fifty-seven percent of converted eyes were detected by both methods.

Conclusions : Analysis of patterns of RNFLT using GEM can detect glaucoma in more eyes than linear regression of global average RNFLT before the onset of repeatable SAP abnormality.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×